Caspase cleavage product lacking amino-terminus of IκBα sensitizes resistant cells to TNF-α and TRAIL-induced apoptosis

Journal of Cellular Biochemistry

Volumn 85, Issue 2, 2002, Pages 334-345

  Kim, Ki Woo ^a   Kim, Byung Ju ^a   Chung, Chul Woong ^a   Jo, Dong Gyu ^a   Kim, In Ki ^a   Song, You Hyun ^a   Kwon, Yun Kyung ^a   Woo, Ha Na ^a   Jung, Yong Keun ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Apoptosis; Caspase; I B ; TNF ; TRAIL

Indexed keywords

ASPARTIC ACID; CASPASE; ETOPOSIDE; FAS ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MUTANT PROTEIN; PACLITAXEL; PROTEIN SUBUNIT; SERINE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SENSITIZATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASPARTIC ACID; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CASPASES; DNA PRIMERS; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; FEMALE; FIBROBLASTS; HUMANS; I-KAPPA B PROTEINS; LUCIFERASES; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PACLITAXEL; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036212505     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10139     Document Type: Article

References (55)

1. Identification and characterization of murine caspase-14, a new member of the caspase family
2. Human ICE/CED-3 protease nomenclature
3. Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha
4. Phosphorylation of IκB-α inhibits its cleavage by caspase CPP32 in vitro
5. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
6. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leu-kemia HL-60 cells and thymocytes
7. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation
8. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteosome pathway
9. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control
10. Proapoptotic effects of Tau cleavage product generated by caspase-3
11. Proteases to die for
12. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
13. Involvement of an ICE-like protease in Fas-mediated apoptosis
14. Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis
15. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptosis by growth factor withdrawal by stabilizing a form of metabolic arrest
16. The Ikappa B proteins: Members of a multifunctional family
17. Tumor necrosis factor-alpha-inducible IkappaB alpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappaB activation
18. A general method for in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
19. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways
20. ERICE, a novel FLICE activable caspase
21. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis
22. Correction of radiation in Ataxia Telangiectasia cells by a truncated IκBα
23. Suppression of interleukin-1β-converting enzyme-mediated cell death by insulin-like growth factor
24. Apoptosis: Its significance in cancer and cancer therapy
25. Differences between drug-sensitive and drug-resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26
26. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition
27. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
28. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
29. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop
30. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis
31. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
32. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro
33. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway
34. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta
35. Caspase structure, proteolytic substrates, and function during apoptotic cell death
36. Caspases: Killer proteases
37. Caspases: The protease of the apoptotic pathway
38. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme
39. Apoptosis promotes a caspase-induced amino-terminal truncation of IκBα that functions as a stable inhibitor of NF-κB
40. Caspases as targets in stroke and neurodegenerative diseases
41. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis
42. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product
43. Caspaes: Enemies within
44. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli
45. CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells
46. Life and death decisions: Regulation of apoptosis by proteolysis of signaling molecules
47. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
48. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
49. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
50. NF-kappaB anti-apoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
51. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins
52. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappaB-alpha in transformed chicken spleen cells
53. N- and C-terminal sequences control degradation of Mad3/IκBα in response to inducers of NF-κB activity
54. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
55. Apoptosis in the nervous system